Health Condition 1: R12- Heartburn
Conditions
Interventions
Intervention1: Qurs Atash: 2 tablets orally thrice daily to be taken with water after meals for six weeks
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects of either sex in the age group of 18-65 years 2. Subjects presenting with any of the following symptoms: Retrosternal burning Epigastric pain with retrosternal heaviness Waterbrash Anorexia Nausea or Vomiting SourBelching Sour/Bitter Taste Indigestion Fatigue
Exclusion criteria
Exclusion criteria: 1. Pregnant/Lactating women 2. History of previous GIT surgery 3. History of Hematemesis orMelena 4. Any systemic diseases like Cardiovascular, Respiratory, Hepato-Biliary and Renal Diseases 5. Any metabolic diseases like Diabetes 6. Chronic tobacco chewers or smokers 7. Alcoholism 8. Allergy/Hypersensitivity to any ingredients of the drug. 9. Known cases of Peptic Ulcer disease, Crohnâ??s Disease, Zollinger-Ellison Syndrome and Carcinoma of gastro-intestinal tract
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in signs and symptoms of Humuzat-e-Meda(Hyperacidity)Timepoint: 2weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessment Timepoint: Investigations will be done at baseline and end of treatment | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed